NanoLogix Inc (NNLX)

[Mr Moe]

I am shocked! Utterly Shocked. I can't believe that OTC Financial would have a favorable profile of Nanologix. I mean Nanologix only hired them three weeks ago. I guess offering a negative review would have jeopardized their long term consulting relationship.

But seriously, who can take this seriously? I mean if they paid me $90,000 I would write that NNLX is going to be the second coming of Microsoft.

Instead of hiring a consulting firm to say nice things about NNLX, perhaps NNLX should focus on business at hand.

Moe


OTC Financial Network Issues Favorable Corporate Profile on NanoLogix
SHARON, Pa., Aug. 15 /PRNewswire-FirstCall/ -- NanoLogix, Inc. (OTC: NNLX), a nano-biotechnology company engaged in the development and commercialization of technologies for the creation of hydrogen bioreactors, today announced that OTC Financial Network, a division of National Financial Communications Corp. and the nation's leading micro/small-cap investor relations firm, issued a favorable InvestorFacts report on NanoLogix. The report highlights NanoLogix's technological advantages, market opportunities, growth strategies and management team. To read the report online, visit http://otcfn.com/nnlx/report.html or call 781-444-6100 for reprints.

Geoffrey J. Eiten, publisher of OTC InvestorFacts, stated, 'NanoLogix's current hotbed of opportunity is in commercializing its proprietary and patented hydrogen bioreactor process to create alternative energy sources from industrial and municipal waste streams. As consumers continue to feel the affects of skyrocketing oil and gas prices, finding alternative renewable sources of energy remains a national priority. The generation of hydrogen demonstrates NanoLogix' capability to convert its prolific intellectual property portfolio into much needed alternative energy sources.'

Eiten continued, 'NanoLogix has assembled a stellar leadership team that lends long-standing strategic and international business relationships to better the Company's competitive and marketing position. The Company is targeting thousands of potential new clients, primarily municipalities, multinational energy concerns and those in the industrial sector, providing investors a ground floor opportunity to maximize returns over the long-term.'

About OTC Financial Network

Since 1992, OTC Financial Network has provided consulting services and customized, proactive investor relations campaigns to more than 500 small/micro-cap public companies. OTC Financial Network designs and implements results-driven direct mail, electronic marketing, shareholder communications and other programs to increase market awareness on behalf of its clients. A partnership with OTC Financial Network can improve a company's shareholder communications channel, facilitate capital formation opportunities, create an expanding and diversified base of institutional and retail shareholders, and garner financial media coverage. OTC Financial Network is a division of National Financial Communications Corp. based in Needham, MA. For more information visit http://www.otcfn.com/ and http://www.nationalfc.com.

About NanoLogix, Inc.

NanoLogix is an industry innovator in the research, development and commercialization of nano-biotechnologies, applications and processes. The Company owns or has the rights to an extensive portfolio of 32 patented technologies and 22 more applications are pending. The Company is currently focused on the production of hydrogen from agricultural feedstock, industrial wastewater and municipal waste streams to create new sources of energy. NanoLogix is successfully operating a hydrogen bioreactor at Welch's Food and has recently signed an agreement with the City of Erie Wastewater Treatment Plant for a prototype bioreactor installation. Additionally, NanoLogix develops and markets diagnostic test kits for use in early detection of infectious human diseases such as cancer, cystic fibrosis and AIDS, and owns a patent for the non-toxic induction of apoptosis ('cell suicide') for the treatment of cancer. For more information on the Company, visit http://www.nanologix.net.

Disclaimer: OTC Financial Network, a division of National Financial Communications Corp., serves as special advisor to NanoLogix, Inc. and has received fees for services, in the amount of ninety thousand dollars for one year of service, payable in restricted shares plus an option to purchase an aggregate of five hundred thousand shares of restricted common stock at an exercise price of forty cents per share, plus expenses, for the creation and distribution of materials, including the InvestorFacts report. This is not an offer to buy or sell securities. Information or opinions in this release are presented solely for informative purposes, and are not intended nor should they be construed as investment advice. Additional compensation information and a full disclaimer can be found online by visiting http://www.otcfn.com/nnlx and selecting the 'Disclaimer' link.

This press release contains statements, which may constitute 'forward- looking statements' within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of NanoLogix, Inc., and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.


Contact:
At OTC Financial Network
Geoffrey Eiten
Investor Relations
781-444-6100x613
[e-mail]
www.otcfn.com/nnlx

SOURCE NanoLogix, Inc.


Source: PR Newswire (August 15, 2006 - 9:29 AM EDT)

News by QuoteMedia
www.quotemedia.com